Related Experiment Video
Updated: Apr 30, 2026

Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus
Published on: October 14, 2022
Treatment of indolent, nonencapsulated cryptococcal meningitis associated with hydrocephalus
Sarah T Garber1, Paul L Penar1
1Department of Neurosurgery, College of Medicine, The University of Vermont, Burlington, Vermont, USA.
Abstract:
Infection with cryptococcal meningitis is uncommon in immunocompetent patients. The major virulence factor is the polysaccharide capsule, while nonencapsulated mutants are generally considered nonpathogenic. The authors present a case of hydrocephalus caused by meningitis from an indolent, nonencapsulated Cryptococcus sp. requiring placement and multiple revisions of a ventriculoperitoneal shunt (VPS). The patient presented with progressively worsening occipital headaches. Computed tomography and magnetic resonance imaging showed significant hydrocephalus with no apparent cause. Her symptoms initially resolved after placement of a VPS, but returned four months later. Cultures of the shunt tubing and cerebrospinal fluid (CSF) showed no bacterial infection. When the symptoms failed to resolve, CSF fungal culture revealed Cryptococcus-like yeast, although the organisms were nonencapsulated, and the cryptococcal antigen was negative. After antibiotic therapy, the symptoms resolved. The unusual clinical presentation delayed the diagnosis, highlighting the importance of understanding the detection, diagnosis, and treatment of meningeal infections caused by C. neoformans.
Insights
A rare case of meningitis caused by nonencapsulated Cryptococcus species led to hydrocephalus in an immunocompetent patient. This unusual presentation highlights the need for comprehensive diagnosis of fungal meningitis.
Area of Science:
- Infectious Diseases
- Neurology
- Mycology
Background:
- Cryptococcal meningitis is typically associated with encapsulated Cryptococcus species and is rare in immunocompetent individuals.
- Nonencapsulated Cryptococcus mutants are generally considered nonpathogenic, making their role in meningitis poorly understood.
- Hydrocephalus is a potential complication of meningitis, often requiring neurosurgical intervention.
Observation:
- A case of hydrocephalus in an immunocompetent patient caused by an indolent, nonencapsulated Cryptococcus species is presented.
- The patient experienced recurrent symptoms despite initial ventriculoperitoneal shunt (VPS) placement and negative bacterial cultures.
- Diagnosis was delayed due to the nonencapsulated nature of the yeast and negative cryptococcal antigen tests.
Findings:
- Cerebrospinal fluid (CSF) fungal cultures eventually identified Cryptococcus-like yeast, despite the absence of a capsule.
- The patient's symptoms resolved following antibiotic therapy, suggesting an atypical response or co-infection.
- Nonencapsulated Cryptococcus species can cause indolent meningeal infections and hydrocephalus in immunocompetent hosts.
Implications:
- This case underscores the importance of considering nonencapsulated Cryptococcus species in the differential diagnosis of meningitis, particularly in cases of unexplained hydrocephalus.
- Diagnostic challenges associated with nonencapsulated strains necessitate awareness and potentially broader testing strategies.
- Further research is needed to elucidate the pathogenicity and optimal treatment of infections caused by these atypical fungal pathogens.
Related Concept Videos
Brain Abscess l: Introduction
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Bacterial Meningitis I: Introduction
Viral Meningitis
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...

